Research output per year
Research output per year
- 11 results
Search results
-
2023
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
Hasselbalch, H. C., Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, M. K., Holmström, M. O., Andersen, M. H., Jensen, C., Karsdal, M. A. & Willumsen, N., 2023, In: Cancers. 15, 17, 47 p., 4323.Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile3 Citations (Scopus)12 Downloads (Pure) -
2021
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms
Hasselbalch, H. C., Elvers, M. & Schafer, A. I., 2021, In: Blood. 137, 16, p. 2152-2160 9 p.Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile62 Citations (Scopus)10 Downloads (Pure) -
2020
Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms
Holmström, M. O., Hasselbalch, H. C. & Andersen, M. H., 2020, In: Cancers. 12, 7, p. 1-21 21 p., 1763.Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile21 Citations (Scopus)81 Downloads (Pure) -
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer
Holmström, M. O., Cordua, S., Skov, V., Kjær, L., Pallisgaard, N., Ellervik, C., Hasselbalch, H. C. & Andersen, M. H., 2020, In: Cancer Immunology, Immunotherapy. 69, p. 315–324Research output: Contribution to journal › Review › Research › peer-review
14 Citations (Scopus) -
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives
Hasselbalch, H. C., Skov, V., Kjær, L., Sørensen, T. L., Ellervik, C. & Wienecke, T., 2020, In: Journal of Neuroinflammation. 17, 13 p., 248.Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile9 Citations (Scopus)39 Downloads (Pure) -
Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Liisborg, C., Hasselbalch, H. K. & Sørensen, T. L., 2020, In: Cancers. 12, 3, 14 p., 573.Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile14 Citations (Scopus)16 Downloads (Pure) -
Rationaler for behandling med januskinase 1/2-hæmning af svært syge patienter med COVID-19-pneumoni
Translated title of the contribution :Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia Research output: Contribution to journal › Review › Research › peer-review
Open Access -
2019
Cancer immune therapy for myeloid malignancies: present and future
Holmström, M. O. & Hasselbalch, H. C., 2019, In: Seminars in Immunopathology. 41, 1, p. 97-109Research output: Contribution to journal › Review › Research › peer-review
13 Citations (Scopus) -
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hasselbalch, H. C. & Holmström, M. O., 2019, In: Seminars in Immunopathology. 41, 1, p. 5-19Research output: Contribution to journal › Review › Research › peer-review
Open AccessFile77 Citations (Scopus)114 Downloads (Pure) -
2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Barbui, T., Tefferi, A., Vannucchi, A. M., Passamonti, F., Silver, R. T., Hoffman, R., Verstovsek, S., Mesa, R., Kiladjian, J-J., Hehlmann, R., Reiter, A., Cervantes, F., Harrison, C., Mc Mullin, M. F., Hasselbalch, H. C., Koschmieder, S., Marchetti, M., Bacigalupo, A., Finazzi, G., Kroeger, N. & 3 others, , 2018, In: Leukemia. 32, 5, p. 1057-1069Research output: Contribution to journal › Review › Research › peer-review
Open Access426 Citations (Scopus) -
2017
Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
Bjørn, M. E. & Hasselbalch, H. C., 2017, In: Expert Review of Hematology. 10, 5, p. 393-404Research output: Contribution to journal › Review › Research › peer-review
25 Citations (Scopus)